The number of women on military missions has been increasing recently. While on military missions, they live in an isolated group dominated by men. Such groups consist of young, sexually active individuals, thus increasing the risk of sexually transmitted infections.
INTRODUCTION
In the situation of an increased incidence of sexually transmitted diseases and the related consequences, it is justifi ed to conduct extensive research on the development of new methods for accurate diagnosis, early identifi cation of infection, causal treatment and especially the implementation of prevention.
A very important issue in the context of sexually transmitted diseases is an increasing presence of women in the residual forces. Their presence in the uniformed services creates the need for more research concerning the issues that may arise due to their participation. Since 1988, women in Poland have been allowed to join the military. According to data published by the Public Opinion Research Center, in 1990 there were 32 women serving in the Polish army, by 1995 that number rose to over 100, 5 years later -almost 300, in 2005 just under 600 [11] and in 2006, more than 650 women served in the army [12] . In 2007, the number of women serving in the military had increased to 800. The number of female candidates for professional military positions surpassed 1000. Individuals relocating to military missions abroad must adjust to the new environment and lifestyle. During military missions, the cohabitation in an isolated group of young men and women significantly increases the risk of infection with sexually transmitted diseases. According to data from the world literature, the most common sexually transmitted infections in a population of quartered, sexually active young men and women, include HPV, HIV, HSV-2 and Chlamydia trachomatis [20] .
Particularly dangerous and oncogenic HPV is spread through sexual contact. Both men and women act as reservoirs, therefore screening of both groups is necessary for prevention of infection [18] . According to data from epidemiological studies, 30-60% of sexually active Poles are infected with genital HPV types [7] . High incidence of latent HPV infection is a clinically signifi cant issue. Pathogen identifi cation requires cytological and molecular studies to identify the type of virus present (low-or high-risk). Those infected, must then be carefully and frequently managed by a gynecologist to help prevent the development of cervical cancer. Routine Pap smears can only confi rm or exclude morphological changes in the cervical epithelial cells, without providing any clues regarding viral DNA's integration into the host's DNA. Therefore, Pap smear can not recognize HPV infection, nor determine its genotype. An eff ective way to detect viral DNA is through molecular tests. Most common tests mark the HPV DNA in a cervical swab using genetic techniques, primarily PCR (polymerase chain reaction). However, these IgE concentration by ELISA method. Determination of anti-HSV-2, HIV and Chlamydia trachomatis antibodies by ELISA method. For the assessment of HPV infections, DNA extracted from cervical squamous epithelial cells was tested by PCR, HPV genotype was examined via the expression of E6 and E7 oncogenes of HPV 16, 18, 33, 35, 45 strains by real-time NASBA.
Human immunodefi ciency virus (HIV) is the etiological factor for the acquired immune deficiency syndrome (AIDS). HIV can lead to infections with opportunistic pathogens (Pneumocystis spp., Toxoplasma gondii, Candida albicans, cytomegalovirus), can cause cancer, including cervical cancer with a high-grade dysplasia, it can also cause degeneration of the nervous system. Transmission of the virus occurs through sexual contact, heterosexual (80%) and homosexual, through contaminated blood or blood products, from mother to child during the last trimester of pregnancy or during childbirth and breastfeeding [16] .
In 2011, 1,290 HIV infections were diagnosed in Poland. This represents more than a double increase in infections compared to the time period 2000-2010. This increase applies only to men [13] .
HSV-2 causes mainly genital herpes, but it could also lead to cancer. Despite therapy, infection persists until the end of life. It is estimated that 60% of infections are undiagnosed, which is the result of insuffi cient medical testing [3] . Infection occurs through direct contact between an individual shedding the virus with damaged skin or undamaged mucosa of the recipient. Men excrete virus more frequently due to anatomical diff erences. During sexual contact, women are 4 times more likely to become infected than men. The risk of infection other than through sexual contact is minimal.
According to the WHO (2003 data), there were 536 million individuals infected with HSV-2 worldwide (315 mln women and 221 mln men between the ages 14 and 49). Frequency of infection is highest in persons around the age of 40. Only 10-25% of those infected are aware of their diagnosis [7] .
In the time period 1990-2003, HSV-2 infection rate was less than 2 per 100,000 individuals. In 2007, 193 cases were recorded in Poland [14] . Medical consequences of HSV-2 genital infection include the possibility of fetal or newborn infection during pregnancy and synergism with HIV infection. HSV infection stimulates the expression of CCR5 on CD4+ lymphocytes, which increases the risk of HIV infection. HSV infection causes breaks in the continuity of the skin and mucosa, increasing the risk of HIV infection.
Chlamydia trachomatis is a mostly sexually transmitted microbe. Risk factors for C. trachomatis infection include: young age, multiple sexual partners, hormonal contraception. C.trachomatis infections are mostly observed in the population of young women, however 70% of infections are asymptomatic. Infl ammation of minor pelvic organs is a commonly observed complication, potentially leading to tubal infertility [4] . studies do not detect persistent infections in which HPV DNA was integrated into the genome of squamous cells. In such cases, test results for the presence of viral DNA are negative. Test does not provide information regarding the development of potential epithelial neoplasia [2] . Chronic infection lasting a few months may be detected by another test that detects high-risk HPV (HR-HPV) mRNA oncogenes E6 and E7 (PreTect HPV-Proofer assay) [9] . This method uses mRNA amplifi cation reaction for the 5 types of highly-oncogenic HPV strains -16, 18, 31, 33 and 45. A positive result confi rms chronic infection in which the viruses lost their mechanism of control and are capable of producing oncogenic protein contributing to tumorigenesis [6] . In 2008-2011, the implementation of the Development Program concerning the screening for particularly important sexually transmitted infections and the development of preventive and therapeutic algorithm in the residual forces, including those on military missions, allowed for the identifi cation of HPV mRNA in a group of 300 women aged 20-35 years. The research was carried out once. In 25 women, E6/ E7 oncogene mRNA transcripts were detected. In 32% of these women, Pap smear results were normal in spite of persistent HR-HPV infection -group I by Papanicolaou, NILM (No Intraepithelial Lesion or Malignancy) by Bethesda system 2001.
The results and conclusions obtained following the implementation of the Development Program validate the rationale for further studies of infection with oncogenic types of HPV.
Valid cytology and negative results of HR-HPV DNA test do not confi rm the absence of chronic HPV infection, which often leads to cervical cancer. In Poland, 3,600 women are diagnosed with this type of cancer annually, while approximately 2,000 die from it every year -this is one of the highest ratios in Europe (9.4/100,000; data from 2004) [5] . In view of the signifi cance of the problem for determining the prevalence of chronic infection, it is advisable to extend the scope of screening in young women. Diagnostic confi rmation of chronic HPV infection enables gynecologists to identify women at higher risk of developing cervical cancer early and manage them with proper specialist medical care. This is especially true considering the fact that the peak for detection of HPV infection occurs in the age group 18-25 years, with peak cervical cancer incidence occurring around the age of 50. Prevalence screening for persistent infection may be part of a cervical cancer prevention program. not possible to reach women stationed on military missions, hence Group II consisted only of 306 male soldiers. Re-examinations were performed on 53 individuals from this group. The remaining male subjects from Group 2 could not take part in re-examinations due to mission prolongation.
Laboratory tests were conducted with the approval of the Institute of Mother and Child Bioethical Committee, as well as with the informed consent of all test groups.
During the study, laboratory tests consisted of: a) complete blood count, b) subpopulations of blood cells using monoclonal antibodies by fl ow cytometry -basic immune panel: CD14/CD45, CD3, CD19, CD4, CD8, CD16+CD56 (NK), c) concentration of cytokines: IL-2, IL-4, TNF-α, IFN -γ, IL-18 by fl ow cytometry method, d) concentration of IgG, IgA, IgM by turbidimetric method and concentration of total IgE using ELISA (Enzyme-Linked Immunosorbent Assay), e) detection of anti-HSV-2, anti-HIV and anti-Chlamydia trachomatis antibodies using ELISA, f ) detection of HPV antigen using PCR (polymerase chain reaction), g) defi ning HPV genotype by expression analysis HPV (16, 18, 33, 35, 45) E6 and E7 oncogene using PCR, NASBA type. Blood cell immunophenotype was determined by fl ow cytometry. Lymphocyte subpopulations were marked using venous blood collected on EDTA and fl uorochrome-labeled antibodies to facilitate the identifi cation of T lymphocytes and their subpopulations, B lymphocytes and NK cells. The measurement was performed in 24 hours and probes were collected at a temperature of 4°C. Serum concentration of immunereactive cytokines: IL-2, IL-4, TNF-α, IFN-γ was carried out using FlowCytomix Human Th1/Th2 11 plex Kit, Bender MedSystems company. Cytokine IL-18 concentration was determined using a similar kit.
ELISA was used in the analysis of a developing HSV or Chlamydia trachomatis infection utilizing anti-HSV and anti-Chlamydia antibodies. The diagnosis of HIV infection was based on ELFA technique in which fl uorescence of the sample is measured spectrophotometrically.
HPV presence was detected by labeling its viral DNA in the squamous epithelial cells collected from the endocervical canal and the sulcus behind the corona of the glans. This method used specifi c oligonucleotide primers and DNA polymerase to multiply specifi c viral DNA sequences from the collected tissue. DNA identifi cation occurred by means of hybridization techniques. For the pur-C.trachomatis facilitates HPV infection by sustaining infl ammation and modifying local epithelial immunity. Infection with the pathogen often coincides with the presence of high risk HPV [17] . According to some authors, C.trachomatis infection can cause epithelial dysplasia or cervical cancer [1] . In men, the most common forms of C.trachomatis include NGU (Non-gonococcal urethritis), epididymitis, especially in young men under 35 y.o., which could cause obstruction of the seminiferous tubules and male infertility. Chlamydial infection may lead to reactive arthritis, which occurs more commonly in men. Infectious agent may trigger immunological process by both cellular and humoral immune response, although no evidence of microorganism within the joint is detected. Infl ammation of the synovial tendon connective tissue capsule is observed [10] .
According to the 2004 data, infection rate of Chlamydia trachomatis in Poland ranged between 20% and 40% [21] . Data concerning Chlamydia trachomatis infection rate after 2010 is lacking.
The objective was to conduct screening and develop a thorough prevention and treatment guideline for specifi c sexually transmitted diseases among residual forces stationed at home and abroad.
METHODS
The immune system prevents infl ammation, which arises as a result of viral or bacterial infections. Its condition was assessed by testing blood cell subpopulations using fl ow cytometry -basic immune panel, cytokine concentrations: IL-2, 4, 18, TNF-α, IFN-γ and immunoglobulin E (total IgE) as a potential factor in allergic diseases. In order to diagnose Chlamydia trachomatis infection, HSV-2 and HIV, serum levels of IgM and IgG antibodies were measured. HPV infection was diagnosed using labeled viral DNA in the squamous epithelial cells of urogenital organs. The survey covered residual forces (military, police, municipal police, border service), examining a total of 579 individuals, up to 35 years of age (172 women and 407 men). Subjects qualifi ed for the study were divided in 2 groups. Group I included individuals who remained in the country. Group II consisted of those who participated in military missions abroad. Clinical and laboratory tests were performed at the beginning ( Study 1) and after a period of 6-12 months (Study 2). One hundred seventy-one subjects took part in Study 2 (84 women, 87 men). Additionally, E6 and E7 gene transcript of high-risk HPV was marked in a group of 200 women. It was
RESULTS

HSV 2 infection
A total of 579 subjects took part in the study (172 women and 407 men). The tests were done twice -at the beginning (Study 1) and after a period of 6 months (Study 2). Study 2 involved 171 individuals (84 women, 87 men). HSV-2 infection was diagnosed by detecting specifi c viral antibodies measured in Virotech Units (VE). Concentration exceeding 11 VE was considered a positive result. No person with anti-HSV-2 IgM antibodies was detected in test group.
Among the tested 579 people, 306 were participants of military missions abroad (Group II) and 273 were stationed in the country (Group I). During Study 1, HSV-2 infection was confi rmed in 4 cases (1.3%) in Group II and in 13 cases (4.8%) in Group I. During Study 2 consisting of 171 individuals out of the original 579, HSV-2 infection was confi rmed in poses of chronic HPV infection confi rmation, E6 and E7 viral transcripts were detected using molecular biology method (NASBA, real-time). The advantage of detecting mRNA transcripts over HPV DNA lies in the diagnosis of chronic infections where viruses may lose their ability to control and begin to synthesize oncogenic proteins aff ecting carcinogenesis.
The serum concentration of a particular immunoglobulin class was measured using turbidimetric method (Turbitimer TT3 device, BEHRING DIAGNOSTICS, INC.), which measures the intensity of light passing through a turbid medium formed after an immunochemical reaction. The results were recorded in international unit/ml (IU/ml). IgE concentration was measured by fl uoroenzymatic method (FEIA, a type of ELISA technique) using ImmunoCAP Phadia-Pharmacia system. 
Chlamydia trachomatis infection
The study involved a total of 579 subjects (172 women and 407 men), 170 individuals participated in Study 2 (83 women, 87 men). Chlamydia trachomatis infection was determined by the presence of specifi c IgM and IgG antibodies measured in NTU (Novatec Unit). Positive result was determined with concentrations above 11 NTU. No Chlamydia trachomatis IgM antibody was confi rmed in the group examined. Out of a total of 579 individuals, 306 left for missions abroad (Group II) and 273 remained in the country (Group I). In Study 1, Chlamydia trachomatis infection was confi rmed in 5 (50%) patients from Group II and in 5 (50%) patients from Group I. In Study 2, a re-examination consisting of 170 out of the original 579 patients, Chlamydia trachomatis infection was confi rmed in 1 (1.9%) out of 52 patients from Group II and in 3 (2.3%) out of 118 patients from Group I. Table 4 shows the dynamics of Chlamydia trachomatis infection in Groups I and II, by gender during Study 1 and 2.
Among 83 women from Group I, Chlamydia trachomatis infection in Study 1 was confi rmed in 2 (2.4%) women. Study 2 of the same group resulted in the following: -one woman remained positive; while in another case the infection was not confi rmed, -in 81 (97.6%) out of 83 women from Study 1, test result for Chlamydia trachomatis infection was negative; while in Study 2, a negative result was confi rmed in 80 women from the group with initial negative results, in 1 case the result has changed to a positive. In Study 1, among the 35 men in Group I, Chlamydia trachomatis infection was confi rmed in 1 man (the same) in Studies 1 and 2. The remaining 34 men were negative for Chlamydia trachomatis infection in studies 1 and 2.
In the second group of 52 soldiers, confi rmation of Chlamydia trachomatis infection was related to the same man in Study 1 and 2. Negative results were confi rmed in 51 men in both studies. Tables 5 and 6 present test results of immunological parameter profi les of the same patients with positive IgG antibodies against Chlamydia trachomatis in Studies 1 and 2 (3 out of 10 positive cases in Study 1; 3 out of 4 positive cases in Study 2 -one woman and two men). One person infected with Chlamydia trachomatis belonged to Group II, while the other belonged to Group I.
In Study 1 (Table 13) , decreased concentration of IgA was observed in one woman from group I (those who remained in the country). Other im-1 out of 52 individuals from Group II (1.9%) and in 10 out of 119 individuals from Group I (8.4%). Table 1 presents the dynamics of an HSV-2 infection in Groups I and II, including both sexes during Study 1 and 2. During Study 1, HSV2 infection was confi rmed in 7 out of 84 women in Group I. During Study 2 of the same group, the following results were found: -6 women continued to have a positive result; in 1 woman the infection was not confi rmed, -In 77 out of 84 women, HSV-2 infection test result was negative during Study 1; while in Study 2 negative result was confi rmed in 74 out of 77 women, in 3 cases the result has changed from negative to positive. Among 35 men from Group I, HSV-2 infection was confi rmed in 1 case during Study 1 and 2. HSV-2 infection test result was negative in 34 cases during both studies.
In Group 2, a total of 52 male soldiers participated in both studies. Only 1 case (the same one in each study) of HSV-2 infection was confi rmed during Study 1 and 2. Negative test results were confi rmed in 51 men in both studies. Tables 1 and 2 present test results of immunological profi le parameters of the same patients who presented with IgG antibodies against HSV-2 (8 out of 17 positive results in test 1; 8 out of 11 positive results in test 2; 6 women and 2 men) during Study 1 and 2. One person infected with HSV-2 belonged to Group II (mission participant).
The following was observed during Study 1 (table 2) in 3 women from Group I (individuals who remained in the country): -decreased IgA concentration -fi rst woman, -decreased IgM concentration and the number of B lymphocytes (CD19) -second woman, -decreased number of NK cells was observed in a third woman. During the second examination (Table 3) , 1 immunocompromised person was confi rmed with a decreasing concentration of IgG, while in case of the same 2 women from Study 1 decreasing concentration of IgA and IgM was observed. Moreover, in Study 2 there was a decrease in the number of B lymphocytes and NK cells in the same women.
Analysis of cytokine concentrations had shown an increase in the median concentration of IFN-γ, IL-2, IL-18, IL-4 and TNF-α during Study 2 compared to the median concentrations of these cytokines during Study 1, a statistically not signifi cant diff erence. cases in group I. High-risk infection was found in 36 (6.3%) patients, including 15 (4.9%) patients in Group II and 21 (8%) patients in Group I. Mixed infections (high-and low-risk) were detected in 3 (5%) cases -2 (7%) in Group II and 1 (4%) in Group I. Due to small amount of sample material, HPV DNA could not be determined in 145 (25.6%) cases out of 118 (38.6%) in Group II and in 27 (10.3%) in Group I.
A total of 171 individuals participated in Study 2, including 52 persons from Group II and 119 persons from Group I. No infection was detected in 121 (70.8%) out of a group of 171 persons, including 31 patients (59.6%) in Group II and 90 (75.6%) patients in Group I. Low risk HPV infection was found in 5 individuals in Group I, whereas high risk HPV infection in 9 individuals (17.3%) in Group II and in 7 individuals (5.9%) in group I. Mixed infection was found in 1 person from Group I. Due to insuffi cient amount of sample material, HPV DNA mune parameters in all patients were in the reference range.
Analysis of cytokine concentrations was impossible to assess due to a small number of patients infected with Chlamydia trachomatis.
HPV infection
The study involved a total of 567 subjects (162 women and 405 men). Study 2 involved 171 subjects (84 women, 87 men). HPV was detected by determining the DNA in the cells of the squamous epithelium of samples taken from the cervical canal or the sulcus behind the corona of the glans.
In Study 1, a total of 306 out of 567 persons left for missions abroad (Group II) and 261 persons remained in the country (Group I). In Study 1, HPV infection was not detected in 156 (51%) patients in Group II and 201 (77%) -in Study 1, HPV DNA was undetermined in 8 patients. In Study 2, HPV infection was not detected in 2 cases, while in 6 instances HPV DNA was undetermined due to small amount of sample material.
Immunological parameter results of patients in which HPV infection was found in Studies 1 and 2 (8 out of 65 positives in Study 1 and 8 out of 22 positives in Study 2; 5 women and 3 men) are shown in Tables 8 and 9 . Six persons belong to Group I, while 2 individuals belong to Group II.
There was no impairment in humoral immunity in Study 1 (Table 8 ) and Study 2 ( Table 9 ). In Study 1, reduced levels of CD4 were fond in one person and reduced levels of NK cells also in 1 person. In Study 2, reduced number of NK cells was confi rmed in one person.
An analysis of cytokine concentrations showed a decline in the median plasma levels of IL-18 in Study 2 as compared to Study 1. Concentration analysis of other cytokines was impossible to perform.
The analysis showed a decrease in the median concentration of IL-18 in Study 2, as compared to the median concentration of IL-1. Concentration analysis of other cytokines was impossible to perform.
Determination of E6 and E7 gene mRNA of highly-oncogenic HPV types (16, 18, 31, 
33, 45)
The analysis was performed once in a group of 200 women ages 20-35 years. E6/E7 mRNA transcripts were detected in 17 women (Table 10) . HPV 16 infection was detected in 15 women (including 1 case of mixed infection with HPV18 and 1 with HPV33). In one case, only HPV18 infection was diagnosed, while in another only HPV33 was detected.
Pap smears were performed in all cases. HPV16 infection was diagnosed in 2 patients with group I cytology (based on Papanicolaou). These women did not have a history of infl ammation. In 2 cases, two types of HPV infection were diagnosed (16 and 18, and 16 and 33). Both patients had changes in the endothelial cells, one had high-level HSIL, the other LSIL/CIN1. A history of recurrent infl ammation of the genital tract was reported in both women. In a third patient with confi rmed HPV16 infection cytology showed intraepithelial lesions, including high-level koilocytosis and the probability of CIN1. History taking revealed recurrent infl ammation of the genital tract was determined. Recurrent infl ammation of the genital tract and Group II cytology were found during the examination in 14 patients.
was not determined in 28 (16.4%) cases, including 12 (23.1%) from Group II and 16 (13.4%) from Group I.
In study 1, HPV infection was not detected in 74 out of 84 women (Table 7) from Group I. While in Study 2, the same group of women presented with the following results: -no infection in 67 women, 3 women at low risk of infection, 1 woman with high risk of infection, undetermined data in 3 patients due to small amount of HPV DNA sample material, -low-risk infection was confi rmed in 1 case where high-risk HPV infection was identifi ed in Study 2 -in Study 1, high-risk HPV infection was confi rmed in 8 women in whom in Study 2: no infection was detected in 4 women, high-risk HPV infection was found in 3 women, and in 1 woman mixed-type infection was found, -due to small amount of sample material, no HPV DNA determination was made in one person in Study 1 and Study 2.
In Group II, 33 out of 52 soldiers (Table 7) were negative for HPV infection in Study 1. In Study 2 conducted on the same group, the following results were found: -no infection in 20 men. High-risk HPV infection was confi rmed in 5 patients. In 8 cases HPV DNA was undetermined due to low amount of sample material, -in 6 cases low-risk HPV infection was confi rmed in Study 1. In study 2 of the same group HPV DNA could not be determined, in 3 cases, while in 2 soldiers infection with high-risk was confi rmed, and no infection was not detected in 1 person, -in study 1, undetermined HPV DNA was found in 13 men. In study 2 of the same group, highrisk infection was found in 2 patients, no infection was detected in 10 patients, in 1 case HPV DNA was undetermined.
In the fi rst group consisting of 35 men (Table  7) , HPV infection was not detected in 24 patients in Study 1. In Study 2, the same group presented with the following: -re-infection was not detected in 15 cases. Lowrisk infection was found in 2 individuals. High-risk infection was confi rmed in 1 person. In 6 cases HPV DNA was undetermined due to small amount of sample material, -in study 1, low-risk infection was confi rmed in 2 men. In study 2, one of them was not confi rmed, while in the second case HPV DNA was not determined due to small amount of sample material, -high-risk HPV infection was found in 1 man in Study 1 and later confi rmed in Study 2, A slight immunodefi ciency was occasionally detected and was unrelated to the confi rmed infections. Increased IgE concentration was found in 22% of patients with no obvious symptoms of allergic disease. There was no association between sexually transmitted infections and elevated levels of IgE. Especially interesting are the results of a study concerning prevalence of HPV infection, particularly with the use of mRNA genes E6 and E7. Previously developed diagnostic algorithm for the detection of HPV infection has not yet fully utilized the signifi cance of mRNA tests in the potential diagnosis of cervical cancer caused by this pathogen. It is recommended to perform the mRNA E6 and E7 gene tests in males. Incidence of sexually transmitted infections in women departing on missions abroad remains an open issue, largely due to the diffi culty in reaching these patients.
CONCLUSIONS
1. In the groups studied, the frequency of analyzed HPV, HIV, HSV2 and Chlamydia trachomatis infection is lower than the rate published in the world literature and comparable to the rate of infection occurring in the general Polish population. 2. There are no signifi cant diff erences between comparative analysis of Group I (persons remaining in the country) and Group II (persons temporarily residing abroad). Completed studies have not confi rmed an increase in incidence of HSV2, Chlamydia trachomatis, HIV or HPV infections in a group of individuals going on military missions abroad compared to those remaining in the country.
on tests 1 and 2: IFN-g (52-64%), IL-2 (34-56%), IL-4 (48-64%), TNF-α (69-74%) and IL-18 (3-13%) in Study 1 and 2 (Table 13) . Cytokine distributions that are diff erent from the norm are concentrated on small values; therefore the mean value and standard deviation do not properly depict their characteristics. The median values for each cytokine in Study 1 and Study 2 are diff erent enough that they do not form any specifi c pattern, as shown by the percentile distribution and histograms.
SUMMARY
Research concerning sexually transmitted infections in the residual forces participating in military missions was made under the Development Project Number O R00002405. This is the fi rst innovative research of such type carried out among groups of uniformed services personnel that pertains the frequency of sexually transmitted infections taking into account immunodefi ciency. Accordingly, the discussion was replaced by an extended summary.
Frequency of the analyzed HPV, HIV, HSV2, Chlamydia trachomatis infections and the selected immunological parameters of the groups tested have trended favorably in comparison with the rate of infection in the general Polish population. The study shows that the incidence of sexually transmitted infections is lower than that described in the world literature There are no signifi cant diff erences in the comparative analysis of Group I (patients remaining in the country) and Group II (temporarily residing abroad). The completed studies have not found an increase in the incidence of HSV-2, Chlamydia trachomatis, HIV or HPV infections in a group of patients going on missions abroad, as compared to those remaining in the country. It should also be noted that Group II consisted of fewer subjects (extended stay out of the country resulted in a lower number of tests being performed in this group).
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